Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Phase II Trial of LM103 in Advanced Melanoma [Phase 2]
Phase II clinical trial of LM103 for melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma [EARLY_Phase 1]
An early-phase clinical trial update evaluating adjuvant therapy guided by pathologic response after neoadjuvant treatment with encorafenib …
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: IDOV-Immune for Advanced Solid Tumors [Phase 1]
This report summarizes a Phase 1 trial of IDOV-Immune from ViroMissile, Inc. for advanced solid tumors, which is currently recruiting across…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma [NA]
Clinical trial investigating IFN-gamma expression as a predictor of response to immune checkpoint inhibitors in first-line metastatic melano…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma [Phase 1]
Phase 1 trial update for XL888 in combination with Vemurafenib and Cobimetinib in unresectable, BRAF-mutated stage III/IV melanoma; the stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update for HMBD-501 evaluating safety, tolerability, pharmacokinetics, and preliminary efficacy in HER3-e…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating molecular profiling-guided matched targeted therapy in patients with unresectable advanced or metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma [Phase 1]
This Phase 1 trial studied the combination of trametinib and ceritinib in patients with unresectable or advanced melanoma and has completed.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
This clinical trial update describes immune-related toxicity and symptom burden in chronic melanoma survivors receiving adjuvant immune chec…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Influence of a High-fiber Diet on the Microbiota and the Response to Immunotherapy in Patients Treated for Melanoma.
This clinical trial investigates whether a high-fiber diet modulates gut microbiota to improve the effectiveness of immunotherapy in melanom…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: ACT-TIL and ANV419 for Advanced Melanoma. [Phase 1]
Phase 1 clinical trial update for ACT-TIL and ANV419 in advanced melanoma. The study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry [NA]
A clinical trial evaluating measurement of tissue oxygen in cutaneous tumors (skin cancer and melanoma) using electron paramagnetic resonanc…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Promoting Immunotherapy Efficacy With Low-Dose Liver RT [NA]
A clinical trial evaluating whether low-dose liver radiotherapy can boost immunotherapy efficacy in non-small cell lung cancer, melanoma, an…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma [Phase 2]
A Phase 2 trial evaluating a polarized dendritic cell (aDC1)-based treatment in combination with Interferon Alpha-2, Rintatolimod, and Celec…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) [Phase 3]
Phase 3 trial comparing IMC-F106C regimen versus nivolumab regimens in previously untreated advanced melanoma; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Lavender Aromatherapy for Preoperative Anxiety in Melanoma and Epithelioma Patients [NA]
A completed trial evaluated lavender aromatherapy for reducing preoperative anxiety in patients with melanoma or non-melanoma skin cancer.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Video Education With Result Dependent dIsclosure [NA]
A Dana-Farber Cancer Institute clinical trial update for a study on video education with result-dependent disclosure, currently recruiting, …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for AB821 in adults with locally advanced or metastatic solid tumors. The study is currently recruiting, with …
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) [Phase 3]
A Phase 3 clinical trial comparing Tebentafusp regimen versus investigator's choice in previously treated advanced melanoma is currently rec…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Navigation Intervention for Adolescent and Young Adult Cancer Survivors [NA]
A Kaiser Permanente-sponsored clinical trial update describes a navigation intervention for adolescent and young adult cancer survivors. The…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers
A completed clinical trial evaluating an AI medical device to help primary care practitioners identify and manage skin conditions in adults …
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
The clinical trial evaluating an AI diagnostic tool for primary care doctors assessing skin conditions has been completed. The study evaluat…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Circulating Tumor DNA in Melanoma Patients [NA]
Completed clinical trial investigating circulating tumor DNA in melanoma patients; the update summarizes the trial status and findings.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy® [Phase 3]
Phase 3 trial evaluating JPB898, a nivolumab biosimilar, in combination with ipilimumab for melanoma, was terminated after an integrated PK/…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for tegavivint in recurrent or refractory solid tumors, including lymphomas and desmoid tumors, currently …